Skin Research Training

Lab Info

Name:
Biobank LOEX

Principal investigator:
Ms. Veronique Moulin

Location:
Quebec, Quebec

Contact:
Veronique Moulin
veronique.moulin@fmed.ulaval.ca

Objective/description

The advancement of biomedical research including regenerative medicine, tissue engineering reconstruction of different tissues and organs as well as the understanding of physiological, pathophysiological mechanisms and pharmacotoxicological and cosmetological analyzes.

Collection Details

Skin conditions represented:

• Normal healthy skin

Anatomic sites:

• Skin abdomen
• Breast
• Face
• Arm

Specimen types:

• Tissue:
  • OCT TM embedded
  • Formalin Fixed Paraffin Embedded (FFPE)
• Cell & cell lines:
  • Fresh (live viable cells)
    
  • Cryopreserved cells

Lab Info

Name:
Piguet Lab

Principal investigator:
Dr. Vincent Piguet

Location:
Toronto, Ontario

Contact:
David Croitoru
David.croitoru@mail.utoronto.ca

Objective/description

We are engaged in translational research of inflammatory dermatoses and perturbation of immune regulation and microbial communities at associated disease sites.

Collection Details

Skin conditions represented:

• Pyoderma Gangrenosum
• Hidradenitis Suppurativa
• Psoriasis
• Normal skin

Anatomic sites:

• All areas

Specimen types:

• Tissue:
  • Frozen
• Blood & blood derivatives:
  • Whole blood
  • Fluid derivatives (plasma, serum)
• Swabs
  • Traditional Microbiology
• Other
  • Stool

Lab Info

Name:
CTTB Biobank and Registry for Atopic dermatitis

Principal investigator:
Dr. Carolyn Jack

Location:
Montreal, Quebec

Contact:
Gaurav Isola
gaurav.isola@mail.mcgill.ca

Objective/description

The Transdisciplinary Centre for Biological Therapies (Centre Transdisciplinaire de Thérapies Biologiques or CTTB) is a multidisciplinary, integrated approach for patients who are receiving therapies directed at the immune system. The CTTB Biobank and Registry for Atopic dermatitis has been created to collect and store blood, skin tissue and other types of biological samples, as well as clinical information, for current and future research purposes.

Objectives:
To identify the impact of various treatments for dermatitis on patient symptoms, quality of life and disease outcome.
To characterize (including potential sequencing) skin lesions and matched normal tissues at the molecular and cellular level (the cells, the DNA, RNA and proteins, as well as their regulatory factors), to help better understand disease biology, prognosis and response to therapy, with a potential to identify new targets for improved treatments.
To characterize cells, proteins and genetic material (RNA and DNA) in the blood or other bodily fluids to identify characteristics that may act to identify specific kinds of skin diseases, or to predict response to therapy or disease outcome.

To characterize biomarkers, including those related to microbiome (bacteria that live on or in humans) to identify potential disease markers, markers of response to therapy or prognostic markers.

Collection Details

Skin conditions represented:

• Atopic dermatitis
• Normal skin

Anatomic sites:

• Skin area with active lesion (antecubital fossa, popliteal fossa, flexural neck etc.)
• Peri lesional skin area (around the lesional area)
• Non-lesional skin area matching the corresponding lesional area

Specimen types:

• Tissue:
  • Frozen
  • OCT TM embedded
• Cell & cell lines:
  • hbuhbmnkj
• Blood & blood derivatives:
  • Fluid derivatives (plasma, serum)
  • Cellular derivatives – Peripheral blood mononuclear cells
• Other derivatives
  • RNA
  • DNA
• Swabs
  • Traditional Microbiology
  • Genomic Analysis

• Other
  • kljasdflkasfd